Mohit Pahuja, Adam Johnson, Ryan Kabir, Sukhdeep Bhogal, Jason P Wermers, Nelson L Bernardo, Itsik Ben-Dor, Hayder Hashim, Lowell F Satler, Farooq H Sheikh, Ron Waksman
The use of mechanical circulatory support devices in cardiovascular practice has risen exponentially over the past decade. These devices are currently used for hemodynamic support in patients with cardiogenic shock, high-risk percutaneous coronary intervention, left ventricular unloading, protection of kidneys, and right ventricular failure. The Impella (Abiomed) percutaneous microaxial flow pump devices are rapidly gaining popularity. However, despite their increasing use, there are limited randomized clinical trials (RCTs) to support the benefits of the therapy and growing concern regarding complication rates...
November 22, 2022: Journal of the American College of Cardiology